Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20233751

Company安庆回音必制药股份有限公司

Registration Date

June 21, 2023

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（按氨氯地平计）

Drug Type

化学药品

Registration Date

June 21, 2023

Company Information

Applicant Company

Company Name安庆回音必制药股份有限公司

Company Address

皖岳西县长宁工业区

Manufacturing Company

Company Name回音必集团抚州制药有限公司

Company Address

江西省抚州市金巢开发区钟岭工业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy